510(k) Report

FDA applicant

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular

Irvine, CA33 decisions2011–202514 recalls

FDA records 33 decisions for Micro Therapeutics, Inc. d/b/a ev3 Neurovascular (Irvine, CA) from 2011 to 2025: 32 510(k) clearances and 1 original PMA approval. Most are in product codes NRY (Catheter, Thrombus Retriever) and POL (Neurovascular Mechanical Thrombectomy Device…). Since 2016 its 510(k)s took a median of 103 days from receipt to decision, against 110 for FDA’s reviews in the same codes and years. Its devices cite 54 predicates, 27 of them its own earlier devices. 14 recalls are linked to its devices, 11 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Micro Therapeutics, Inc. d/b/a ev3 Neurovascular’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2011: 12014: 22015: 32016: 32017: 42018: 62019: 22020: 52021: 42024: 22025: 1
2011high 6 (2018) · low 0 (2012)2026

2026 so far, outlined.

Recalls per year

2in 2025

2013: 12014: 1, 1 Class I2015: 12016: 4, 4 Class I2018: 1, 1 Class I2020: 1, 1 Class I2021: 2, 2 Class I2022: 12025: 2, 2 Class I
2011high 4 (2016) · low 0 (2011)2026

Class I Class II/III not classified

FIG. 1 — Micro Therapeutics, Inc. d/b/a ev3 Neurovascular by year, 2011–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Micro Therapeutics, Inc. d/b/a ev3…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report